RG-7166

N/A

Report date: 2022/02/14 14:04:41
NME

Base Information

Drug NameRG-7166
Drug Alias NameRG-7166
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonistsAdrenergic receptors antagonistsSerotonin transporter inhibitors
TargetsDopamine transporterAdrenergic receptorsSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A